Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.
Figarella-Branger D, Mokhtari K, Dehais C, Jouvet A, Uro-Coste E, Colin C, Carpentier C, Forest F, Maurage CA, Vignaud JM, Polivka M, Lechapt-Zalcman E, Eimer S, Viennet G, Quintin-Roué I, Aubriot-Lorton MH, Diebold MD, Loussouarn D, Lacroix C, Rigau V, Laquerrière A, Vandenbos F, Michalak S, Sevestre H, Peoch M, Labrousse F, Christov C, Kemeny JL, Chenard MP, Chiforeanu D, Ducray F, Idbaih A; POLA Network. Figarella-Branger D, et al. Among authors: carpentier c. Neuro Oncol. 2014 Sep;16(9):1244-54. doi: 10.1093/neuonc/nou047. Epub 2014 Apr 9. Neuro Oncol. 2014. PMID: 24723566 Free PMC article.
Association of telomerase gene hTERT polymorphism and malignant gliomas.
Carpentier C, Lejeune J, Gros F, Everhard S, Marie Y, Kaloshi G, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Sanson M. Carpentier C, et al. J Neurooncol. 2007 Sep;84(3):249-53. doi: 10.1007/s11060-007-9378-3. Epub 2007 Apr 5. J Neurooncol. 2007. PMID: 17410334
TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: carpentier c. Cancer Genet Cytogenet. 2007 Sep;177(2):103-7. doi: 10.1016/j.cancergencyto.2007.06.010. Cancer Genet Cytogenet. 2007. PMID: 17854663
Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors.
Idbaih A, Boisselier B, Marie Y, Sanson M, El Hallani S, Crinière E, Fourtassi M, Paris S, Carpentier C, Rousseau A, Mokhtari K, Combadière C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: carpentier c. Brain Res. 2008 Mar 10;1198:16-20. doi: 10.1016/j.brainres.2008.01.027. Epub 2008 Jan 18. Brain Res. 2008. PMID: 18262501
Chromosome 1p loss evaluation in anaplastic oligodendrogliomas.
Idbaih A, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros JM, French P, Teepen JL, Delattre O, Delattre JY, van den Bent M, Hoang-Xuan K. Idbaih A, et al. Among authors: carpentier c. Neuropathology. 2008 Aug;28(4):440-3. doi: 10.1111/j.1440-1789.2008.00863.x. Epub 2008 Feb 26. Neuropathology. 2008. PMID: 18312547
Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas.
Idbaih A, Crinière E, Marie Y, Rousseau A, Mokhtari K, Kujas M, El Houfi Y, Carpentier C, Paris S, Boisselier B, Laigle-Donadey F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: carpentier c. Neuro Oncol. 2008 Aug;10(4):540-7. doi: 10.1215/15228517-2008-022. Epub 2008 Jun 10. Neuro Oncol. 2008. PMID: 18544654 Free PMC article.
Genomic changes in progression of low-grade gliomas.
Idbaih A, Carvalho Silva R, Crinière E, Marie Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A, Mokhtari K, Ducray F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: carpentier c. J Neurooncol. 2008 Nov;90(2):133-40. doi: 10.1007/s11060-008-9644-z. Epub 2008 Jul 11. J Neurooncol. 2008. PMID: 18618226
Bevacizumab and irinotecan for recurrent oligodendroglial tumors.
Taillibert S, Vincent LA, Granger B, Marie Y, Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D, Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson M, Delattre JY. Taillibert S, et al. Among authors: carpentier c. Neurology. 2009 May 5;72(18):1601-6. doi: 10.1212/WNL.0b013e3181a413be. Neurology. 2009. PMID: 19414728
149 results